Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 03-Nov-2022 titled Alembic Pharmaceuticals announces its second injectable product approval from its General Sterile Facility - Final Approval for Ketorolac Tromethamine Injection USP.